Verteporfin: A Review of its Use in the Management of Subfoveal Choroidal Neovascularisation

Author： Keam S.J.   Scott L.J.   Curran M.P.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.63, Iss.22, 2003-01, pp. : 2521-2554

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Verteporfin: A Review of its Use in the Management of Subfoveal Choroidal Neovascularisation

By Fenton Caroline   Perry Caroline M.  

Drugs & Aging, Vol. 23, Iss. 5, 2006-01 ,pp. : 421-445

Adis International

Access to resources Recommend Favorite

Spotlight on Verteporfin in Subfoveal Choroidal Neovascularisation

By Keam S.J.   Scott L.J.   Curran M.P.  

Drugs & Aging, Vol. 21, Iss. 3, 2004-01 ,pp. : 203-209

Adis International

Access to resources Recommend Favorite

Pharmacogenetic Aspects in Therapeutic Management of Subfoveal Choroidal Neovascularisation: Role of Factor XIII-A 185 T-Allele

By  

Current Drug Targets, Vol. 12, Iss. 2, 2011-02 ,pp. : 138-148

Bentham Science Publishers

Access to resources Recommend Favorite

Verteporfin: Aggravation of choroidal neovascularisation in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1414, 2012-01 ,pp. : 48-49

Adis International

Access to resources Recommend Favorite

Safety of verteporfin for treatment of subfoveal choroidal neovascular membranes associated with age-related macular degeneration

By Gaynes Bruce I   Fiscella Richard G  

Expert Opinion on Drug Safety, Vol. 3, Iss. 4, 2004-07 ,pp. : 345-361

Informa Healthcare

Access to resources Recommend Favorite